Alfredo
Adán Civera
Publikationen, an denen er mitarbeitet Alfredo Adán Civera (2)
2022
-
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
The Lancet, Vol. 399, Núm. 10326, pp. 729-740
-
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
The Lancet, Vol. 399, Núm. 10326, pp. 741-755